{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:15:53Z","timestamp":1790957753006,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.vascn.2021.107054","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T19:22:27Z","timestamp":1616786547000},"page":"107054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Optimization of psoriasis mouse models"],"prefix":"10.1016","volume":"108","author":[{"given":"Christina","family":"Karamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivi Theodosia","family":"Antoniadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Dimou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Andreou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Kostakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asimina","family":"Sideri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Vitsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena","family":"Gkavanozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Sfiniadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Skaltsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios Theodoros","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail Christou","family":"Rallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Maibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vascn.2021.107054_bb0005","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/ijps.IJPS_245_16","article-title":"Acetic acid dressings: Finding the holy grail for infected wound management","volume":"50","author":"Agrawal","year":"2017","journal-title":"Indian Journal of Plastic Surgery: Official Publication of the Association of Plastic Surgeons of India"},{"key":"10.1016\/j.vascn.2021.107054_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.physbeh.2013.06.010","article-title":"Effects of long-term etanercept treatment on anxiety- and depression-like neurobehaviors in rats","volume":"119","author":"Bayramg\u00fcrler","year":"2013","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.vascn.2021.107054_bb0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbi.2017.08.001","article-title":"Th17 cells in depression","volume":"69","author":"Beurel","year":"2018","journal-title":"Brain, Behavior, and Immunity"},{"issue":"12","key":"10.1016\/j.vascn.2021.107054_bb0020","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.3390\/ijms18122514","article-title":"Models in the research process of psoriasis","volume":"18","author":"Boche\u0144ska","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/j.vascn.2021.107054_bb0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/17460441.2018.1463214","article-title":"Murine models of psoriasis and their usefulness for drug discovery","volume":"13","author":"Chuang","year":"2018","journal-title":"Expert Opinion on Drug Discovery"},{"issue":"4","key":"10.1016\/j.vascn.2021.107054_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.17","article-title":"Regulation of immune cell function by short-chain fatty acids","volume":"5","author":"Corr\u00eaa-Oliveira","year":"2016","journal-title":"Clin Transl Immunology"},{"issue":"7","key":"10.1016\/j.vascn.2021.107054_bb0035","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/exd.13676","article-title":"Inhibition of interleukin-12 and\/or interleukin-23 for the treatment of psoriasis: What is the evidence for an effect on malignancy?","volume":"27","author":"Ergen","year":"2018","journal-title":"Experimental Dermatology"},{"issue":"1","key":"10.1016\/j.vascn.2021.107054_bb0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jdv.15879","article-title":"Biologic therapies targeting the interleukin (IL)-23\/IL-17 immune axis for the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis","volume":"34","author":"Erichsen","year":"2020","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"12","key":"10.1016\/j.vascn.2021.107054_bb0045","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/eji.201343801","article-title":"TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasis","volume":"43","author":"Flutter","year":"2013","journal-title":"European Journal of Immunology"},{"issue":"1","key":"10.1016\/j.vascn.2021.107054_bb0050","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jid.2017.10.013","article-title":"Research techniques made simple: Murine models of human psoriasis","volume":"138","author":"Hawkes","year":"2018","journal-title":"The Journal of Investigative Dermatology"},{"issue":"6","key":"10.1016\/j.vascn.2021.107054_bb0055","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis","volume":"201","author":"Hawkes","year":"2018","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/j.vascn.2021.107054_bb0060","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1038\/s41598-019-39903-x","article-title":"Methodological refinement of Aldara-induced psoriasiform dermatitis model in mice","volume":"9","author":"Horv\u00e1th","year":"2019","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/j.vascn.2021.107054_bb0065","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/ced.13378","article-title":"Depression- and anxiety-like behaviour is related to BDNF\/TrkB signalling in a mouse model of psoriasis","volume":"43","author":"JiaWen","year":"2018","journal-title":"Clinical and Experimental Dermatology"},{"issue":"1","key":"10.1016\/j.vascn.2021.107054_bb0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13041-018-0407-2","article-title":"Distribution of Caskin1 protein and phenotypic characterization of its knockout mice using a comprehensive behavioral test battery","volume":"11","author":"Katano","year":"2018","journal-title":"Molecular Brain"},{"issue":"1","key":"10.1016\/j.vascn.2021.107054_bb0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5021\/ad.2015.27.1.26","article-title":"Histopathological findings are associated with the clinical types of psoriasis but not with the corresponding lesional psoriasis severity index","volume":"27","author":"Kim","year":"2015","journal-title":"Annals of Dermatology"},{"key":"10.1016\/j.vascn.2021.107054_bb0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2015.03.010","article-title":"Therapeutic and immunomodulatory effects of glucosamine in combination with low-dose cyclosporine a in a murine model of imiquimod-induced psoriasis","volume":"756","author":"Kim","year":"2015","journal-title":"European Journal of Pharmacology"},{"issue":"Jun 21","key":"10.1016\/j.vascn.2021.107054_bb0085","article-title":"Management of psoriasis as a systemic disease: What is the evidence?","author":"Korman","year":"2019","journal-title":"The British Journal of Dermatology"},{"issue":"2","key":"10.1016\/j.vascn.2021.107054_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/exd.13467","article-title":"Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities","volume":"27","author":"Krueger","year":"2018","journal-title":"Experimental Dermatology"},{"issue":"1","key":"10.1016\/j.vascn.2021.107054_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12895-016-0046-1","article-title":"Effect of 12-O-tetradecanoylphorbol-13-acetate-induced psoriasis-like skin lesions on systemic inflammation and atherosclerosis in hypercholesterolaemic apolipoprotein E deficient mice","volume":"16","author":"Madsen","year":"2016","journal-title":"BMC Dermatology"},{"issue":"3","key":"10.1016\/j.vascn.2021.107054_bb0105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jdv.12106","article-title":"Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The correlation between disease severity and psychological burden in patients treated with biological therapies","volume":"28","author":"Mattei","year":"2014","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"1","key":"10.1016\/j.vascn.2021.107054_bb0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bcp.2013.08.006","article-title":"Animal models of human disease: Challenges in enabling translation","volume":"87","author":"McGonigle","year":"2014","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"10.1016\/j.vascn.2021.107054_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clim.2014.12.011","article-title":"Deficiency of both L-selectin and ICAM-1 exacerbates imiquimod-induced psoriasis-like skin inflammation through increased infiltration of antigen presenting cells","volume":"157","author":"Mitsui","year":"2015","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.vascn.2021.107054_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellsig.2017.02.014","article-title":"GPR43 activation enhances psoriasis-like inflammation through epidermal upregulation of IL-6 and dual oxidase 2 signaling in a murine model","volume":"33","author":"Nadeem","year":"2017","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.vascn.2021.107054_bb0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2017.05.018","article-title":"IL-17A causes depression-like symptoms via NF\u03baB and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression","volume":"97","author":"Nadeem","year":"2017","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.vascn.2021.107054_bb0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/1346-8138.14112","article-title":"Mouse models of psoriasis and their relevance","volume":"45","author":"Nakajima","year":"2018","journal-title":"The Journal of Dermatology"},{"issue":"1","key":"10.1016\/j.vascn.2021.107054_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16707-5","article-title":"The systemic response to topical Aldara treatment is mediated through direct TLR7 stimulation as Imiquimod enters the circulation","volume":"7","author":"Nerurkar","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vascn.2021.107054_bb0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cellimm.2018.09.001","article-title":"IL-17 and limits of success","volume":"339","author":"Omidian","year":"2019","journal-title":"Cellular Immunology"},{"issue":"2","key":"10.1016\/j.vascn.2021.107054_bb0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jid.2017.09.019","article-title":"How effective is Tacrolimus in the Imiquimod-induced mouse model of psoriasis?","volume":"138","author":"Pischon","year":"2018","journal-title":"The Journal of Investigative Dermatology"},{"issue":"9","key":"10.1016\/j.vascn.2021.107054_bb0150","first-page":"884","article-title":"Clinical evaluation of a multi-modal facial serum that addresses hyaluronic acid levels in skin","volume":"16","author":"Raab","year":"2017","journal-title":"Journal of Drugs in Dermatology"},{"issue":"2","key":"10.1016\/j.vascn.2021.107054_bb0155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/bjd.12371","article-title":"Psychological differences between early- and late-onset psoriasis: A study of personality traits, anxiety and depression in psoriasis","volume":"169","author":"Remr\u00f6d","year":"2013","journal-title":"The British Journal of Dermatology"},{"issue":"6","key":"10.1016\/j.vascn.2021.107054_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.vascn.2021.107054_bb0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuropharm.2018.09.016","article-title":"Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression","volume":"143","author":"Staton","year":"2018","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.vascn.2021.107054_bb0170","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.intimp.2014.12.032","article-title":"Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation","volume":"24","author":"Sun","year":"2015","journal-title":"International Immunopharmacology"},{"issue":"6","key":"10.1016\/j.vascn.2021.107054_bb0175","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/jid.2012.512","article-title":"IL-1R1 signaling facilitates Munro\u2019s microabscess formation in psoriasiform imiquimod-induced skin inflammation","volume":"133","author":"Uribe-Herranz","year":"2013","journal-title":"The Journal of Investigative Dermatology"},{"issue":"9","key":"10.1016\/j.vascn.2021.107054_bb0180","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"Van der Fits","year":"2009","journal-title":"Journal of Immunology"},{"issue":"3","key":"10.1016\/j.vascn.2021.107054_bb0185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1534734619856143","article-title":"Efficacy of a Ceratothoa oestroides olive oil extract in patients with chronic ulcers: A pilot study","volume":"18","author":"Vitsos","year":"2019","journal-title":"The International Journal of Lower Extremity Wounds"},{"key":"10.1016\/j.vascn.2021.107054_bb0190","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/ncomms2566","article-title":"Aldara activates TLR7-independent immune defence","volume":"4","author":"Walter","year":"2013","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/j.vascn.2021.107054_bb0200","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/art.38227","article-title":"Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women","volume":"66","author":"Wu","year":"2014","journal-title":"Arthritis & Rhematology"},{"issue":"3","key":"10.1016\/j.vascn.2021.107054_bb0205","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.38298","article-title":"Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: A new model of systemic lupus erythematosus","volume":"66","author":"Yokogawa","year":"2014","journal-title":"Arthritis & Rhematology"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871921001064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871921001064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:04:36Z","timestamp":1761005076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871921001064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":39,"alternative-id":["S1056871921001064"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2021.107054","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.03.05.978775","asserted-by":"object"}]},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of psoriasis mouse models","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2021.107054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107054"}}